Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
1,08 USD | +69,01 % | +53,74 % | +96,36 % |
Métier
Nombre d'employés: 81
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
René Russo
CEO | Chief Executive Officer | 49 | 22/05/19 |
Kevin Brennan
DFI | Director of Finance/CFO | 54 | - |
Chief Tech/Sci/R&D Officer | - | 01/10/22 | |
Chief Operating Officer | 42 | 01/03/21 | |
Uli Bialucha
CTO | Chief Tech/Sci/R&D Officer | - | 01/04/21 |
Julissa Viana
IRC | Investor Relations Contact | - | - |
Scott Coleman
PRN | Corporate Officer/Principal | - | 01/06/22 |
Brian King
AUD | Comptroller/Controller/Auditor | - | 01/03/23 |
Allene Diaz
PRN | Corporate Officer/Principal | 59 | - |
Stacey J. Davis
PRN | Corporate Officer/Principal | - | 17/05/22 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Paul Clancy
CHM | Chairman | 62 | 23/07/20 |
Daniel Curran
BRD | Director/Board Member | 57 | 01/12/20 |
Tomas Jan Heyman
BRD | Director/Board Member | 68 | 15/09/22 |
Sara Bonstein
BRD | Director/Board Member | 43 | 17/08/21 |
Robert Ross
BRD | Director/Board Member | 50 | 16/06/22 |
René Russo
CEO | Chief Executive Officer | 49 | 22/05/19 |
Christina Rossi
BRD | Director/Board Member | 48 | 01/04/21 |
Yuan Xu
BRD | Director/Board Member | 56 | 04/01/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 27 555 074 | 24 376 830 ( 88,47 %) | 13 074 ( 0,0474 %) | 88,47 % |
Coordonnées société
Secteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+96,36 % | 17,59 M | |
+9,30 % | 45,97 Md | |
+52,73 % | 43,93 Md | |
+7,15 % | 42,34 Md | |
-8,78 % | 28,27 Md | |
+18,68 % | 27,18 Md | |
-21,92 % | 19,44 Md | |
+14,62 % | 13,83 Md | |
+31,85 % | 12,4 Md | |
+4,47 % | 11,45 Md |
- Bourse
- Actions
- Action Xilio Therapeutics, Inc. - Nasdaq
- Société Xilio Therapeutics, Inc.